Provided with the increasing number of patients diagnosed with ALS and the improved
societal awareness of the disease, more resources should be allocated to the research and …

Edaravone, the first known free radical scavenger, has demonstrated cellular protective
properties in animals and humans. Owing to its antioxidant activity, edaravone modulates …

Background and Objectives Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative
disorder affecting upper and lower motor neurons. Due to its rarity and rapidly progressive …

Objective Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease and
information on disease burden of ALS in mainland China was limited. We aimed to estimate …

Objective To establish whether amyotrophic lateral sclerosis (ALS) is a multistep process in
South Korean and Japanese populations when compared to Australian cohorts. Methods …

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are severe
neurodegenerative disorders that belong to a common disease spectrum. The molecular …

Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative motor neuron disease.
Although an early diagnosis is crucial to provide adequate care and improve survival …

Increased incidence rates of amyotrophic lateral sclerosis (ALS) have been recently
reported across various Western countries, although geographic and temporal variations in …

Multidisciplinary care (MDC) has been the most recommended approach for symptom
management in amyotrophic lateral sclerosis (ALS) but there is conflicting evidence about its …

Amyotrophic lateral sclerosis (ALS) is a fatal disease related to upper and lower motor
neurons degeneration. Although the environmental and genetic causes of this disease are …